Satisfaction to start the vaccination campaign

The launch of the vaccination campaign in India against COVID-19 on Saturday was successful with at least 190,000 people receiving a dose, the Indian Ministry of Health said, but one of the vaccines used is a cause for concern in some parts of the population.

The second most populous country in the world estimates to vaccinate 300 million people, almost as many as the US population, by July, as part of one of the largest vaccination campaigns in the world.

Vaccines are given with two vaccines: Covaxin developed by Bharat Biotech and the Medical Research Council of India, and Covishield by AstraZeneca and the University of Oxford. Both were produced by the Serum Institute of India and licensed for emergency use in early January.

“We had encouraging and satisfying results on the first day,” Indian Health Minister Hars Vardan told his Indian counterparts on Saturday.

“This vaccine will indeed be ‘Sanjeevani’ (life-saving),” he added.

India is the second most affected country in the world – after the United States – by COVID-19 with more than 10 million reported infections, although officially the mortality rate is one of the lowest in the world.

The Ministry of Health said no “case of hospitalization after vaccination” was reported, but local media reported that a security guard at the All India Institute of Medical Sciences (AIIMS), the country’s main public hospital, had an allergic reaction immediately after vaccination. .

An agency representing doctors at Ram Manohar Lohia Hospital in New Delhi wrote a letter asking that only Covishield of the University of Oxford and AstraZeneca be used instead of Covaxin, in order to allay concerns that complete the Phase 3 tests.

“People are a little worried about the fact that the Covaxin trials have not been completed and may not be very involved, which could jeopardize the purpose of the vaccine,” he said in a letter seen by AFP.

“We ask you to vaccinate us with ‘Covishield’ which has completed all the tests before it was developed.”

Concerns about vaccines are very widespread in India. A recent poll of 18,000 people found that 69% of citizens are in no hurry to get the vaccine.

Source: by

*The article has been translated based on the content of by If there is any problem regarding the content, copyright, please leave a report below the article. We will try to process as quickly as possible to protect the rights of the author. Thank you very much!

*We just want readers to access information more quickly and easily with other multilingual content, instead of information only available in a certain language.

*We always respect the copyright of the content of the author and always include the original link of the source article.If the author disagrees, just leave the report below the article, the article will be edited or deleted at the request of the author. Thanks very much! Best regards!